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Editors: Anton N. Sidawy and Bruce A. PerlerGenetic and environmental contributions to abdominal aortic aneurysm
development in a twin population
Carl Magnus Wahlgren, Emma Larsson, Patrik K.E. Magnusson, Rebecka
Hultgren, Jesper Swedenborg
Background: The contribution of hereditary and environmental factors to
the development of abdominal aortic aneurysms (AAAs) is still partly
unknown. The aim of this study was to analyze the role of these factors in
a large population-based sample of twins.
Methods: The Swedish Twin Registry, containing data on twins born in the
country since 1886, was cross-linked with the Inpatient Registry, providing
national coverage of discharge diagnoses coded according to the Interna-
tional Classification of Diseases (ICD). All twins with an infrarenal AAA were
identified. Concordance rates and tetrachoric correlations were calculated
for monozygotic (MZ) and dizygotic (DZ) twins. Tetrachoric correlations
were calculated assuming an underlying normal distribution of liability, with
multiple factors contributing additively and a threshold value that discrim-
inates between AAA and no AAA. Higher concordance rates and correlations
of liability in MZ twins than in DZ twins suggest that genetic factors influ-
ence disease development. Structural equation modeling techniques, Mx-
analyses, were used to estimate the contributions of genetic effects as well
as shared and nonshared environmental factors for development of AAA.
Results: There were 172,890 twins registered at the time of the study
including 265 twins (81% men; mean age 72 years; range, 48-94) with AAA.
There were 7 MZ and 5 DZ concordant pairs as well as 44 MZ and 197 DZ
discordant pairs with AAA. The probandwise concordance rates for MZ and
DZ pairs were 24% and 4.8%, respectively. The tetrachoric correlations were
0.71 in MZ pairs and 0.31 in DZ pairs. The odds ratio (OR) was 71 (95% confi-
dence interval [CI] 27-183) for MZ twins and 7.6 (95% CI 3.0-19) for DZ twins.
In the structural equation models, genetic effects accounted for 70% (95% CI
0.33-0.83), shared environmental effects for 0% (95% CI 0-0.27), and non-
shared environmental effects for 30% (95% CI 0.17-0.46) of the phenotypic
variance among twins.
Conclusion: These data provide robust epidemiologic evidence that herita-
bility contributes to aneurysm formation. Concordances and correlations
were higher in MZ compared with DZ twins, indicating genetic effects. There
was a 24% probability that an MZ twin of a person with AAA will have the
disease. The twin of an MZ twin with AAA had a risk of AAA that was 71 times
that of the MZ twin of a person without AAA. A heritability of 70% of the total
trait variance was estimated. The remaining variance was explained by non-
shared environmental factors with no support for a role of shared environ-
mental influences.Cost-effectiveness of abdominal aortic aneurysm repair based on
aneurysm size
Kate C. Young, Nadia A. Awad, Marcia Johansson, David Gillespie, Michael J.
Singh, Karl A. Illig* Full articles available online at www.jvascsurg.org
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doi:10.1016/S1078-5884(09)00630-3Objective: To evaluate the cost-effectiveness of endovascular repair (EVAR)
for small abdominal aortic aneurysms (AAA).
Methods: We developed a Markov model of a hypothetical 68-year-old
cohort to determine the cost-effectiveness of early EVAR for ‘‘small’’ AAAs
(4.0 cm-5.4 cm) compared with elective repair (open or endovascular) at
the traditional cut-off of 5.5 cm. Repair options for 5.5-cm AAAs include
both endovascular and open procedures. Probabilities were obtained from
the literature. Costs reflected direct costs in 2007 dollars. Outcomes were
reported as quality-adjusted life-years (QALYs).
Results: The model demonstrated that early EVAR for 4.0 cm-5.4 cm AAAs
led to fewer QALYs at greater costs when compared with observational
management with elective repair at 5.5 cm. Sensitivity analyses suggested
that early EVAR of 4.6 cm-4.9 cm AAAs can be cost-effective if the long-term
mortality rate after EVAR is 1.91% per year or if the quality of life after
EVAR is improved. Likewise, if the quality of life before repair is low, EVAR
for AAAs 4.6 cm may be cost-effective. With a >70% probability, observa-
tional management until AAA diameter is 5.5 cm will be the cost-effective
option.
Conclusions: This analysis demonstrated that early EVAR for AAAs <5.5 cm is
not likely to be cost-effective compared with elective repair at 5.5 cm.
However, EVAR for small AAAs may become cost-effective when differences
in quality of life and mortality are considered.The impact of renal insufficiency on the outcome of carotid surgery is
influenced by the definition used
Benjamin Kretz, Nicolas Abello, Roger Brenot, Eric Steinmetz
Background: Renal insufficiency (RI) seems to be a source of complications
after carotid endarterectomy (CEA). However, published studies do not use
a common definition of RI. Our objective was to analyze the effects of RI on
carotid surgery using three classifications of renal function.
Methods: Using a prospective database, we studied renal function and post-
operative complications in patients operated on between January 1, 2003
and December 31, 2008. Renal function was studied using the level of plasma
creatinine, creatinine clearance calculated according to the Cockcroft
formula, and to the Modification of Diet in Renal Disease (MDRD) equation.
For each method, the patients were divided into three groups: normal renal
function, moderate RI, and severe RI. The principal judgment criterion was
the 30-day non-fatal stroke and death rate.
Results: The analysis concerned 961 CEA carried out in 901 patients. The
30-day non-fatal stroke and death rate was 2%. In the analysis of renal
function using the level of creatinine, there was no statistical difference
between the groups in the 30-day stroke and death rate (normal renal func-
tion: 1.8%, moderate: 2.7%, severe: 8.3%, P = .21). The analysis of renal
function according to creatinine clearance calculated using the Cockcroft
formula showed that in the severe RI group, the stroke and death rate was
higher than in the other two groups (normal renal function: 1.7%, moderate
RI: 1.4%, severe RI: 7.5%, P = .004). Analysis using the MDRD formula showed
similar differences between the severe RI group and the other two with high-
er rate of 30-day stroke and death (normal renal function: 1.4%, moderate
Abstracts 121RI: 1.7%, severe RI: 12.5%, P < .001). Sub-group analysis showed that among
patients with severe RI according to the creatinine clearance, those with
symptomatic carotid stenosis had the highest incidences of non-fatal stroke
and death (Cockroft, n = 19: 21.1%, MDRD, n = 10: 40%).
Conclusion: Severe RI is a risk factor for complications after carotid surgery.
Creatinine clearance calculated according to the MDRD formula correlates
most closely with these complications. Symptomatic patients with severe
RI, according to the creatinine clearance, are at high risk with a very high
level of postoperative complications.Detection of common carotid artery stenosis using duplex ultrasonography:
A validation study with computed tomographic angiography
David P. Slovut, Javier M. Romero, Kathleen M. Hannon, James Dick, Michael
R. Jaff
Background: Severe stenosis of the common carotid artery (CCA), while
uncommon, is associated with increased risk of transient ischemic attack
and stroke. To date, no validated duplex ultrasound criteria have been
established for grading the severity of CCA stenosis. The goal of this study
was to use receiver-operating curve (ROC) analysis with computed
tomographic angiography as the reference standard to establish duplex
ultrasound criteria for diagnosing 50% CCA stenosis.
Methods: The study cohort included 64 patients (42 men, 22 women) with
a mean age of 65  12 years (range, 16-89 years) who had CCA peak systolic
velocity (PSV) 150 cm/sec and underwent computed tomographic angiog-
raphy (CTA) of the cervical and intracerebral vessels within 1 month of the
duplex examination. One study was excluded because the CTA was techni-
cally inadequate, whereas another was excluded because the patient under-
went bilateral CCA stenting. The CCA ipsilateral to any of the following was
excluded from the analysis: innominate artery occlusion (n = 1), previous
stenting of the ICA or CCA (n = 7), carotid endarterectomy (n = 1), or
carotid-to-carotid bypass (n = 1). Thus, the data set included 62 patients
and 115 vessels. Bland-Altman analysis was used to examine the agreement
between two measures of luminal reduction measured by CTA: percent
diameter stenosis and percent area stenosis. Receiver operating character-
istic (ROC) analysis was used to determine optimal PSV and EDV thresholds
for diagnosing 50% CCA stenosis.
Results: Severity of CCA stenosis was <50% in 76 vessels, 50%-59% in eight,
60%-69% in eight, 70%-79% in nine, 80%-89% in three, 90%-99% in five, and
occluded in six. Duplex ultrasonography identified six of six (100%) patients
with 100% CCA occlusion by CTA. Bland-Altman analysis showed poor agree-
ment between percent stenosis determined by vessel diameter compared
with percent stenosis determined by reduction in lumen area. Therefore,
subsequent analysis was performed using percent stenosis by area. ROC
analysis of different PSV thresholds for detecting stenosis 50% showed that
>182 cm/sec was the most accurate with a sensitivity of 64% and specificity
of 88% (P < .0001). Sensitivity, specificity, and accuracy of carotid duplex
were higher when the stenosis was located in the mid or distal aspects of
the CCA (sensitivity 76%, specificity 89%, area under curve 0.84, P < .001)
than in the intrathoracic and proximal segment of the artery (P = NS). ROC
analysis of different EDV thresholds for detecting CCA stenosis 50% showed
that >30 cm/sec was the most accurate with a sensitivity of 54% and a spec-
ificity of 74% (P < .0239).
Conclusions: Duplex ultrasonography is highly sensitive, specific, and accu-
rate for detecting CCA lesions in the mid and distal CCA. Use of peak systolic
velocity may lead to improved detection of CCA disease and initiation of
appropriate therapy to reduce the risk of stroke.Aggressive lipid-lowering is more effective than moderate lipid-lowering
treatment in carotid plaque stabilization
Nikolaos P.E. Kadoglou, Nikolaos Sailer, Anestis Moumtzouoglou, Alkistis
Kapelouzou, Thomas Gerasimidis, Christos D. Liapis
Objective: Atherosclerotic plaque stabilization is a promising strategy to
prevent cerebrovascular events in patients with carotid atherosclerosis.
Vascular calcification inhibitors, known osteopontin (OPN) and osteoprote-
gerin (OPG), have emerged as novel cardiovascular biomarkers. This open-
label, prospective study aimed to examine whether aggressive lipid-lowering
therapy with atorvastatin is more effective than moderate lipid-lowering inincreasing carotid plaque echogenicity, assessed by Gray-Scale Median (GSM)
score and suppressing serum OPN and OPG levels in patients with moderate
carotid stenosis.
Methods: One hundred forty patients (64 males, 76 females), aged 50 to 75
years, with carotid stenosis (North American Symptomatic Carotid Endarter-
ectomy Trial [NASCET]: 30%-60% for symptomatic and 30%-70% for asymp-
tomatic), but without indications for surgical intervention, were enrolled.
Patients with coronary heart disease, renal failure, hypothyroidism, osteo-
porosis, and ongoing use of statins were excluded. Patients were randomly
assigned to: Group A (N = 70): Moderate lipid-lowering therapy with low-dose
of atorvastatin (10 mg-20 mg) to target LDL-C <100 mg/dL. Group B (N = 70):
Aggressive lipid-lowering therapy with high-dose of atorvastatin (80 mg) to
target LDL-C <70 mg/dL. Blood pressure, lipid and glycemic indexes, hsCRP,
serum OPN, and OPG were measured at baseline and after 12 months as well
as the GSM score. Independent samples t test, paired samples t test, Pearson
correlation, and multiple regression analysis were used (P < .05).
Results: There were no significant differences between groups at baseline.
Three patients in group A experienced either cerebrovascular or cardiac
ischemic attacks, while two patients in group B underwent coronary angio-
plasty during follow-up. Group B showed a more pronounced improvement
in total cholesterol and LDL-cholesterol compared with group A (P < .05).
Moreover, atorvastatin treatment suppressed serum hsCRP, OPN, and OPG
levels from baseline in both groups (P < .001). Notably, aggressive treatment
decreased OPN (P = .012) and OPG (P = .025) levels to a greater degree
compared with moderate treatment. Similarly, GSM score was remarkably
increased in both groups, but that augmentation was greater in group B
(from 66.39  23.66 to 100.4  25.31) than in group A (from 64.4  23.62
to 85.39  20.21) (P = .024). No change in the degree of carotid stenosis
was noted in both treatment arms. Importantly, the aforementioned reduc-
tion in OPN (r = 0.517, P = .024) and OPG (r = 0.312, P = .008) levels was
inversely associated with GSM score changes in univariate and standard
multiple regression analysis (R2 = 0.411, P = .021).
Conclusions: Among patients with moderate carotid stenosis, an aggressive
atorvastatin regimen enhanced carotid plaque echogenicity and reduced
serum OPN and OPG levels to a greater extent than respective moderate
atorvastatin therapy. Most importantly, those atorvastatin-induced effects
were associated with OPN and OPG suppression in a dose-dependent
manner.Infectious complications after elective vascular surgical procedures in the
United States
Todd R. Vogel, Viktor Y. Dombrovskiy, Jeffrey L. Carson, Paul B. Haser,
Stephen F. Lowry, Alan M. Graham
Objective: This study was conducted to evaluate and compare the rates of
postoperative infectious complications and death after elective vascular
surgery, define vascular procedures with the greatest risk of developing
nosocomial infections, and assess the effect of infection on health care
resource utilization.
Methods: The Nationwide Inpatient Sample (2002-2006) was used to identify
major vascular procedures by International Classification of Diseases, 9th
Clinical Modification (ICD-9-CM) codes. Infectious complications identified
included pneumonia, urinary tract infections (UTI), postoperative sepsis,
and surgical site infections (SSI). Case-mix-adjusted rates were calculated
using a multivariate logistic regression model for infectious complication
or death as an outcome and indirect standardization.
Results: A total of 870,778 elective vascular surgical procedures were
estimated and evaluated with an overall postoperative infection rate of
3.70%. Open abdominal aortic surgery had the greatest rate of postoperative
infections, followed by open thoracic procedures and aorta-iliac-femoral
bypass. Thoracic endovascular aneurysm repair (TEVAR) infectious complica-
tion rates were two times greater than after EVAR (P < .0001). Pneumonia
was the most common infectious complication after open aortic surgery
(6.63%). UTI was the most common after TEVAR (2.86%) and EVAR (1.31%).
Infectious complications were greater in octogenarians (P < .0002), women
(P < .0001), and blacks (P < .0001 vs whites and Hispanics). Nosocomial
infections after elective vascular surgery significantly increased hospital
length of stay (13.8  15.4 vs 3.5  4.2 days; P < .001) and reported total
hospital cost ($37,834  $42,905 vs $11,851  $11,816; P < .001).
Conclusions: Elective vascular surgical procedures vary widely in the esti-
mated risk of postoperative infection. Open aortic surgery and endarterec-
tomy of the head and neck vessels have, respectively, the greatest and
122 Abstractsthe lowest reported incidence for postoperative infectious complications.
Women, octogenarians, and blacks have the highest risk of infectious
complications after elective vascular surgery. Disparities in the development
of infectious complications on a systems level were also found in larger
hospitals and teaching hospitals. Hospital infectious complications were
found to significantly increase health care resource utilization. Strategies
that reduce nosocomial complications and target high-risk procedures may
offer significant future cost savings.Intermediate-term outcomes of endovascular treatment for symptomatic
chronic mesenteric ischemia
Michael A. Peck, Mark F. Conrad, Christopher J. Kwolek, Glenn M.
LaMuraglia, Vikram Paruchuri, Richard P. Cambria
Objective: Endovascular therapy for chronic mesenteric ischemia (CMI) has
been increasingly utilized. Early outcomes compare favorably with open
mesenteric bypassdthe current gold standard. The goal of this study is
documentation of intermediate-term anatomic and functional outcomes of
endovascular mesenteric revascularization for symptomatic CMI.
Methods: This is a retrospective review of all patients undergoing endovas-
cular treatment of symptomatic CMI from July 2002 to March 2008. Study
endpoints included periprocedural mortality, major morbidity, patency,
symptomatic recurrence, and survival. Endpoints were analyzed using actu-
arial methods.
Results: Sixty-six mesenteric arteries (78.8% stenotic/21.2% occluded) were
treated in 49 patients. One or more vessels were treated in each case;
however, four mesenteric artery total occlusions (3 SMAs/1 IMA) could not
be crossed. Initial symptom relief was noted in 89.8% (n = 44) with no change
in 5 patients. Single-vessel treatments were performed in 32 patients
(65.3%) and two-vessel interventions in 17 (34.7%). The 30-day mortality rate
was 2.0% (n = 1). Major complications occurred in 8 patients (16.3%). Themean follow-up duration was 37.4  2.98 months (range, 0-66). Restenosis
on follow-up imaging occurred in 64.9% (n = 24) of the 37 patients who had
radiographic surveillance at a mean follow-up interval of 8.5  1.9 months
and was diagnosed most often by Duplex scan or computed tomographic
angiography (CTA). Fourteen patients (28.6%) developed recurrent symp-
toms with 13 requiring a reintervention. Actuarial 36-month freedom from
symptomatic recurrence was 60.9%  9.4%. Two-vessel treatment was
protective against symptom recurrence (P = .0014) and reintervention
(P = .0060) by univariate analysis. A total of 19 reinterventions were required
in 14 patients (28.6%) at a mean of 17 months from the original treatment.
Primary patency at 36 months was 63.9  8.5%. Actuarial survival at 48
months was 81.1%  6.1% with no CMI-related deaths in the study cohort.
Conclusion: Intermediate (3-year) follow-up indicates that significant reste-
nosis and symptom recurrence are common following the endovascular
treatment of symptomatic CMI. Thirty percent of the cohort required a rein-
tervention, one-third of which were conversions to surgical reconstruction.
Similar to the surgical paradigm of two-vessel revascularization, endovascu-
lar treatment of multiple mesenteric arteries produced better outcomes. A
first-line endovascular approach to patients with CMI is a reasonable clinical
strategy, but close follow-up is mandatory.Debate: Open versus endovascular repair of popliteal artery aneurysms
Randy D. Moore, Andrew B. Hill
A 72-year-old male presents with a large asymptomatic aneurysm of his left
popliteal artery. He has a history of noninsulin dependent diabetes, hypter-
tension, and prior history of a percutaneous intervention for a coronary
artery stenosis. He is anatomically and physiologically a candidate for
surgical or endovascular repair of his aneurysm. The following debate
attempts to resolve whether open repair remains the gold standard for the
treatment of popliteal artery aneurysms.
